It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
Accelerate therapeutic antibody discovery with integrated screening platforms, rapid lead generation, and developability-focused candidate selection.
Our antibody discovery workflows are designed to rapidly identify high-affinity therapeutic candidates with strong developability profiles. From challenging membrane proteins to complex biologic targets, we tailor each discovery strategy to maximize downstream therapeutic success.
Generate highly specific monoclonal antibodies using robust in vivo immune responses and optimized screening workflows.
Isolate naturally occurring high-affinity antibodies directly from immunized hosts for rapid lead identification.
Optimize antibody affinity, specificity, and developability for downstream therapeutic applications.
Evaluate antigen structure, immunogenicity, and project objectives.
Generate diverse antibody repertoires using optimized discovery platforms.
Identify high-affinity binders using advanced screening technologies.
Validate specificity, affinity, and developability profiles.
Refine promising antibody leads for downstream therapeutic development.
Antibody Discovery for Complex Targets
Proteogenix is the market leader in antibody discovery for complex targets. Whether you’re working with GPCRs, virus-like particles, or MHC peptides, we excel where others struggle. Our expertise spans innovative techniques including VHHs and custom CAR-T cell development, delivering breakthrough solutions that drive your success. Having performed thousands of complex projects, our team of expert can guide you to choose the best method for your project.
Facing challenges with a complex antigen?
Discover our specialized services or contact our team to bring your project to life!
Custom Anti-GPCR Antibodies Custom Virus-Like Particle Antibodies
Custom MHC-peptide complex antibody Find a solution with our experts
4 weeks from antigen to antibody
Rapid antibody discovery workflows enable identification of high-affinity candidates within four weeks from antigen submission.
Proven success with challenging antigens
Validated experience across GPCRs, ion channels, membrane proteins, virus-like particles, and other difficult targets.
Skip 3 weeks of humanization
Our fully human antibody solutions help reduce downstream development time and accelerate therapeutic antibody development.
Find Your Perfect Match: Tailored Antibody Discovery Platforms for Your Unique Project
Ideal for rare epitopes and optimal developability
Generate fully-human antibodies with superior drug-like properties from humanized mice. Perfect when targeting rare epitopes or when developability is critical for therapeutic success.
Hybridoma Development Service
Cost-effective solution with natural affinity maturation
An economical approach leveraging in vivo affinity maturation. Best suited for projects requiring reliable antibodies with budget-friendly cost.
Rapid human antibody generation with specialized libraries
The fastest route to fully human antibodies. Our unique cancer and autoimmune libraries maximize your chances of high-affinity binders for disease-related targets. Ideal for toxic or poorly immunogenic antigens.
Tool
Answer a few questions and find the technology that best fits your target, application and timeline.
Why ProteoGenix
As an experienced antibody discovery company, ProteoGenix supports programs from antigen strategy through lead selection and optimization — with integrated CRO capabilities across discovery, engineering, production, and characterization.
Deep Scientific Experience
Our long track record in antibody and protein science helps design robust discovery plans aligned with real therapeutic goals.
Reliable Execution
Established workflows and experienced teams improve consistency, reproducibility, and confidence in the discovery process.
Long-Term Development Support
We support clients beyond discovery with antibody engineering, production, and characterization services as programs advance. For biotech and pharma teams, working with a company with long-standing technical depth reduces uncertainty and supports faster progress toward therapeutic leads.
Your dedicated PhD expert supports your project from design to completion, providing strategic recommendations and clear go/no-go checkpoints so you can make data-driven decisions at every stage of antibody discovery.
From challenging antigens to complex therapeutic targets, our team designs customized discovery strategies using the most appropriate platform for your project, helping maximize your chances of identifying high-quality antibody candidates.
Your discoveries remain entirely yours. ProteoGenix operates with no IP restrictions or hidden royalty fees, giving you full ownership of generated antibody sequences and complete freedom for downstream development.
“Throughout the project, we greatly benefited from ProteoGenix’s strong scientific and technical expertise, as well as the dedication and responsiveness of our main contact. Their support was instrumental in overcoming key challenges and in accelerating the translational development of our lead candidate.”
_ Dr. Uwe Haberkorn (Head of Department) at Heidelberg University
FAQ
Partner with ProteoGenix for antibody discovery services backed by scientific depth, platform capabilities, and more than 20 years of experience in antibody and biologics development. Our integrated CRO model supports biotech and pharma teams from early target analysis through lead optimization and beyond.
